Basic Information
Basic information for SNHG14-329-11aa-3
Peptide Name SNHG14-329-11aa-3
Genome Position chr15:25222159-25222191[+]
Species Human
Peptide Sequence MVTLKKDFSWA
Peptide Length 11
Unique No (SNHG14-202-11aa-3,SNHG14-203-11aa-1,SNHG14-207-11aa-1,SNHG14-225-11aa-2,SNHG14-228-11aa-1,SNHG14-244-11aa-3,SNHG14-273-11aa-2,SNHG14-285-11aa-1,SNHG14-294-11aa-3,SNHG14-295-11aa-1,SNHG14-317-11aa-2,SNHG14-326-11aa-2,SNHG14-327-11aa-2,SNHG14-331-11aa-1)
Grand Average of Hydropathicity 0.0727
Relative Molecular Mass 1505.76
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000669989;SNHG14-329
Transcript Length 6336
Coding Ability 0.5073
DNA Sequence Corresponding to Peptide ATGGTGACCCTGAAGAAAGACTTCAGTTGGGCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :